GRCE peer analysis
Grace Therapeutics (GRCE) against its competitors: price, today's move, 1-year return and market value side by side.
- GRCE's peers: ABVC (ABVC BioPharma), ATNM (Actinium Pharmaceuticals), CALC (CalciMedica), LTRN (Lantern Pharma), OKUR (OnKure Therapeutics), PDSB (PDS Biotechnology), RNXT (RenovoRx), TVRD (Tvardi Therapeutics).
GRCE and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABVC ABVC BioPharma | $0.88 | -3.34% | -67.65% | $23.74M |
| ATNM Actinium Pharmaceuticals | $1.07 | -0.93% | -21.32% | $33.64M |
| CALC CalciMedica | $1.17 | 0.00% | -92.59% | $8.07M |
| LTRN Lantern Pharma | $0.28 | -13.79% | -91.32% | $4.24M |
| OKUR OnKure Therapeutics | $2.76 | -2.13% | 0.00% | $111.79M |
| PDSB PDS Biotechnology | $0.79 | -2.76% | 4.67% | $43.82M |
| RNXT RenovoRx | $1.05 | -6.25% | 43.34% | $50.66M |
| TVRD Tvardi Therapeutics | $0.95 | -9.03% | -75.93% | $12.64M |
| XLO Xilio Therapeutics | $7.51 | -1.57% | -33.53% | $53.05M |
| GRCE Grace Therapeutics | $1.73 | 0.00% | -44.55% | $36.39M |